CITIGROUP INC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 85 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2021$0
-100.0%
100
-99.1%
0.00%
Q2 2021$21,000
-36.4%
11,600
-30.5%
0.00%
Q1 2021$33,000
-17.5%
16,683
-47.6%
0.00%
Q4 2020$40,000
-66.1%
31,817
-51.5%
0.00%
Q3 2020$118,000
-82.8%
65,557
-19.7%
0.00%
-100.0%
Q2 2020$685,000
+95.7%
81,635
+22.0%
0.00%
Q1 2020$350,000
-55.1%
66,902
-53.2%
0.00%
Q4 2019$780,000
+36.8%
142,887
+22.1%
0.00%
Q3 2019$570,000
-48.3%
117,022
-26.5%
0.00%
Q2 2019$1,103,000
+25.6%
159,141
+26.0%
0.00%
Q1 2019$878,000
+28.6%
126,326
+8.1%
0.00%
Q4 2018$683,000
-23.3%
116,835
-1.0%
0.00%
Q3 2018$891,000
+168.4%
118,013
+79.4%
0.00%
Q2 2018$332,000
-33.5%
65,774
-19.7%
0.00%
Q1 2018$499,000
+33.4%
81,878
+55.6%
0.00%
Q4 2017$374,000
+67.7%
52,633
+68.5%
0.00%
Q3 2017$223,000
+50.7%
31,243
+33.0%
0.00%
Q2 2017$148,000
-40.3%
23,492
-22.0%
0.00%
Q1 2017$248,00030,1000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders